Gilles Edan
-
- Multiple Sclerosis Research Studies 29
- Systemic Sclerosis and Related Diseases 4
- Neurology top 2%
- Peripheral Neuropathies and Disorders 13
- Hematology top 5%
- Iron Metabolism and Disorders 5
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 6
- Neurology top 10%
- Peripheral Neuropathies and Disorders 13
-
- Polyomavirus and related diseases 7
-
- Thyroid Disorders and Treatments 4
-
- Diabetes and associated disorders 3
- Co-authors
- Jacqueline YaouanqEmmanuelle Le PageMarc CoustansEmmanuelle LerayDavid LaplaudJoël OgerMarc VérinR Fauchet
- Partner nations
- FranceSwitzerlandSpain
In The Last Decade
Gilles Edan
61 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Pathology and Forensic Medicine 903
- Neurology 668
- Hematology 255
- Rheumatology 318
- Neurology 126
Countries citing papers authored by Gilles Edan
This map shows the geographic impact of Gilles Edan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Edan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Edan more than expected).
Fields of papers citing papers by Gilles Edan
This network shows the impact of papers produced by Gilles Edan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Edan. The network helps show where Gilles Edan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gilles Edan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2020 | 0 | |
| 3 | 2018 | 7 | |
| 4 | 2018 | 11 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 5 | |
| 7 | Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss | 2012 | 2 |
| 8 | 2010 | 10 | |
| 9 | 2010 | 406 | |
| 10 | 2006 | 3 | |
| 11 | 2005 | 10 | |
| 12 | 2005 | 6 | |
| 13 | 2005 | 77 | |
| 14 | 2003 | 3 | |
| 15 | [Treatment of progressive forms of multiple sclerosis]. | 2001 | 3 |
| 16 | 1998 | 4 | |
| 17 | 1994 | 28 | |
| 18 | [Intrasynovial secretion of antibrucella antibodies]. | 1979 | 0 |
| 19 | [Demonstration by iron overloading study and HLA genotyping of recessive transmission of idiopathic haemochromatosis in two pseudodominant pedigrees (author's transl)]. | 1979 | 3 |
| 20 | Hérédité récessive de l'hémochromatose idiopathique: deux observations de transmission pseudo-dominante reconnue comme récessive par l'étude de la surcharge en fer et des génotypes HLA dan les familles. | 1979 | 3 |
About Gilles Edan
Gilles Edan is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (13 papers), Polyomavirus and related diseases (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Iron Metabolism and Disorders (5 papers), Thyroid Disorders and Treatments (4 papers), Systemic Sclerosis and Related Diseases (4 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (903 citations), Neurology (668 citations) and Hematology (255 citations). Gilles Edan has collaborated with scholars based in France, Switzerland and Spain. Frequent co-authors include Jacqueline Yaouanq, Emmanuelle Le Page, Marc Coustans, Emmanuelle Leray, David Laplaud, Joël Oger, Marc Vérin, R Fauchet, M Bourel and M. Simon. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.